It is demonstrated that CAFs modulate local immunity by selectively masking ILC3-derived IL-22 signaling while preserving ILC1-mediated IFNγ responses while preserving ILC1-mediated IFNγ responses within the TME.
Abstract
Introduction Colorectal cancer (CRC) is a heterogeneous malignancy and a major cause of cancer-related mortality worldwide. Cancer-associated fibroblasts (CAFs) accumulate in tumors and correlate with poor patient survival, suggesting a central role in immune regulation. Patient-derived organoids (PDO) maintain the intra-tumoral cellular heterogeneity of the original tissue, thus, they represent one of the best methods to study human cancers. The tumor microenvironment (TME) contains diverse immune cell populations, including innate lymphoid cells (ILCs), yet how stromal components influence cytokine-driven tumor–immune interactions remains unclear. Methods PDOs from CRC patients were used to screen TME-derived cytokines affecting tumor growth. Organoid-forming efficiency and signaling pathway activation were analyzed following cytokine stimulation in the presence or absence of CAFs. Tumor-infiltrating ILC subsets were characterized in patient samples, and co-culture systems were employed to assess cytokine production and stromal–immune interactions. Results IL-22 was identified as a cytokine that increased PDO-forming efficiency without activating fibroblasts. Although IL-22 typically signals through the JAK–STAT pathway, it unexpectedly activates MAPK signaling in PDO cells. Interestingly, interferon-γ (IFNγ) showed only partial cytotoxic effects on CRC cells. Tumor tissues contained both IFNγ-producing ILC1 and IL-22/IL-17A–producing ILC3 populations. Co-culture with PDOs selectively induced IL-22, but not IL-17A, production in ILC3 cells. Importantly, IL-22 enhanced organoid formation only in the absence of CAFs, whereas IFNγ activity was largely unaffected by stromal context. Discussion These findings demonstrate that CAFs modulate local immunity by selectively masking ILC3-derived IL-22 signaling while preserving ILC1-mediated IFNγ responses. This study emphasizes the importance of stromal context in interpreting cytokine function in CRC and reveals a previously unrecognized mechanism of stromal–immune crosstalk within the TME.
Overall, CAFs are central orchestrators of immune remodeling in liver cancer and contribute to the establishment of an immunosuppressive microenvironment that supports tumor progression and therapeutic resistance.
N. Porro, Silvia Marri, F. Salani et al.· Oncology Research· 0 citations
Cancer-associated fibroblasts (CAFs) are key regulators of tumor progression, immune modulation, and therapeutic resistance within the tumor microenvironment. Advances in single-cell and spatial profiling have revealed substantial heterogeneity among CAF populations, challenging the traditional view of CAFs as a unifor...
Y. Fukui, Hiroaki Kasashima, Nobuhiro Naito et al.· JMA Journal· 0 citations
Cancer-associated fibroblasts (CAFs) are key regulators of tumor progression and therapeutic response in pancreatic ductal adenocarcinoma (PDAC). While CAF-mediated immune modulation has been extensively studied, it remains poorly understood whether adaptive immune cells reciprocally shape CAF heterogeneity and funct...
Jessica Hung, Stephanie L. Silveria, Jenna Vickery et al.· Cancer Research· 0 citations
A VEGFA-associated functional CAF state promotes gastric cancer organoid growth and chemoresistance through paracrine signaling, highlighting the CAF-VEGFA axis as a potential therapeutic target.
Findings reinforce the central role of MDSCs in colorectal cancer progression and highlight their potential as therapeutic targets, but the high heterogeneity of these cells and the lack of standardized methods for their identification remain challenges for their clinical application.
Maria Fernanda Imperio Pereira, Emilly Paschoal de Oliveira, Valéria de Lima Kaminski· Research, Society and Develo...· 0 citations
Cancer-associated fibroblasts (CAFs) are instrumental in tumor progression by interacting with tumor cells, other stromal components, and the extracellular matrix (ECM) within the tumor stroma.
The origin, heterogeneity, and activation mechanisms of CAFs in different cancer types have been widely reported....
Bárbara Martins de Lima Coelho, L. B. Murad, Renata Machado Brandão Costa et al.· Cancer Cell International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.